Hayley French, Phd, Msc (ip), Clp

Biography

Hayley French is the Chief Business Officer & General Counsel of Apitope. She has been with Apitope since November 2010. Dr French brings with her over fifteen years’ experience of negotiating licences and collaborations and managing alliances in the life sciences sector. Prior to joining Apitope, Dr French spent three years at Novartis, based at the Basel headquarters, where she worked closely on all global deals and collaborations in the respiratory division. Prior to Novartis, Dr French worked in the Life Sciences Group of Bird & Bird, London, specialising in advising pharmaceutical and biotech companies. Prior to joining Bird & Bird, she was Head of Commercial Legal Affairs at the Centre for Applied Microbiology and Research (CAMR) in Salisbury, UK. Dr French started her career at University College London Ventures where she was responsible for the development, management and commercialisation of technologies in the life sciences sector. She is immediate past president of the Licensing Executives Society Britain & Ireland, and chair of the Licensing Executives Society International (LESI) meetings committee and vice chair of the education committee. Dr French also sits on the BIA IP advisory group. She teaches on the LESI Intellectual Asset Management courses and is a regular speaker on IP licensing and negotiation. She has a B.Sc. in Microbiology from the University of Liverpool, as well as a PhD in Microbiology and a M.Sc. in intellectual property from the University of London and is a certified licensing professional (CLP).

Research Interest

pharmaceutical and biotech.